NCT00324012
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- Department of Oncology 5073, Rigshospitalet Copenhagen, Denmark
Clinical trial condition
Adrenocortical Carcinoma
Explore clinical trials studying Adrenocortical Carcinoma. Study availability and eligibility vary by location and protocol.
40 public trials
10 recruiting studies
Adrenocortical Carcinoma trial results
NCT00003038
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +36 more
- Locations
-
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
NCT00454103
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
- Locations
-
- Würzburg, Germany
Active, Not Recruiting
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
NCT03333616
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
- Locations
-
- University of California, San Diego Moores Cancer Center La Jolla, California, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
NCT00457587
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +13 more
- Locations
-
- Dept. of Medicine I, University of Wuerzburg Würzburg, Germany
Active, Not Recruiting
Evaluation of Side Effects of Mitotane
NCT00568139
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- University Hospital Würzburg, Germany
Active, Not Recruiting
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
NCT03127774
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adrenal Cortex Diseases, +16 more
- Locations
-
- Columbia University Medical Center New York, United States
Active, Not Recruiting
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
NCT02673333
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- University of Michigan (Data or Specimen Analysis Only) Ann Arbor, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
NCT04358107
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Active, Not Recruiting
Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
NCT05036434
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- National Cancer Center Goyang-si, Gyeonggi-do, South Korea